Simvastatin reduces endothelial activation and damage but is partially ineffective in inducing endothelial repair in systemic sclerosis.Nicoletta Del Papa, Agostino Cortelezzi, Wanda Maglione et al.|PubMed|2008Cited by 47
Bimonthly Administered Long-Acting Cabotegravir and Rilpivirine Are Highly Effective and Well-Tolerated in People With Human Immunodeficiency Virus Above 65 YearsAndrea Calcagno, Paola Pignata, Caterina Candela et al.|Open Forum Infectious Diseases|2025Cited by 0